US2011195899A1PendingUtilityA1

Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid

49
Assignee: AMBRX INCPriority: Dec 22, 2004Filed: Aug 5, 2010Published: Aug 11, 2011
Est. expiryDec 22, 2024(expired)· nominal 20-yr term from priority
Inventors:Anna-Maria A. Hays PutnamYing BuechlerDavid C. Litzinger
A61P 9/04A61P 5/06A61P 43/00A61P 39/06A61P 31/18A61P 9/02A61P 37/02A61P 19/00A61P 1/00A61P 13/12A61K 38/27A61K 9/19A61K 47/26C07K 14/61A61K 9/0019A61K 47/02A61K 47/183C07H 21/04
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Formulations of modified human growth hormone polypeptides are provided.

Claims

exact text as granted — not AI-modified
1 - 53 . (canceled) 
     
     
         54 . A method of treating a patient having a disorder modulated by human growth hormone (hGH) with an effective amount of a pharmaceutical formulation of an hGH polypeptide comprising one or more non-naturally encoded amino acids wherein said formulation comprises:
 a) a buffer;   b) at least one carrier, excipient, or stabilizer;   c) and a pharmaceutically effective quantity of human growth hormone.   
     
     
         55 . (canceled)

Join the waitlist — get patent alerts

Track US2011195899A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.